Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ,etc. by FLIA (Flow Luminescence Immunoassay)
NT-Pro-BNP; ; N-BNP
(Note: Up to 8-plex in one testing reaction)
- Product No.LMA485Ca
- Organism SpeciesCanis familiaris; Canine (Dog) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length1.5h
- Detection Range4.88-5000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 1.627 pg/mL.
- DownloadInstruction Manual
- UOM 8Plex 7Plex 6Plex 5Plex 4Plex 3Plex 2Plex1Plex
- FOB
US$ 449
US$ 467
US$ 492
US$ 527
US$ 562
US$ 613
US$ 691
Result
For more details, please contact local distributors! US$ 864 Add to Price Calculator
Specificity
This assay has high sensitivity and excellent specificity for detection of N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 97-105 | 101 |
EDTA plasma(n=5) | 80-101 | 95 |
heparin plasma(n=5) | 89-98 | 92 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 81-97% | 89-97% | 87-104% | 84-96% |
EDTA plasma(n=5) | 80-101% | 84-97% | 84-95% | 96-103% |
heparin plasma(n=5) | 87-95% | 78-90% | 93-105% | 80-96% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:NT-ProBNP) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 50μL standard or sample to each well,
add 10μL magnetic beads,and 50μL Detection Reagent A,incubate 60min at 37°C on shaker;
3. Wash plate on magnetic frame for three times;
4. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
5. Wash plate on magnetic frame for three times;
6. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Eur Rev Med Pharmacol Sci. | The role of serum n-terminal pro-brain natriuretic peptide in transient tachypnea of the newborn Europeanreview: Source |
Transplantation Proceedings | Vascular Adhesion Protein-1, a Novel Molecule, in Kidney and Heart Allograft Recipients Pubmed: 23769096 |
34 | Paradoxical low-flow, low-gradient aortic stenosis despite preserved left ventricular ejection fraction: new insights from weights of operatively excised aortic valves Pubmed: 24755006 |
Integrative Medicine Insights | A Randomized Controlled Trial to Study the Effect of Yoga Therapy on Cardiac Function and N Terminal Pro BNP in Heart Failure NCBI: PMC3981569 |
Liver Int.? | Diabetes enhances the intrahepatic vascular response to endothelin-1 in cirrhotic rats: association with the ETA receptor and pERK up-regulation. Pubmed:24636620 |
Eur J Heart Fail. | Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Pubmed:24903195 |
Scientific Reports | Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension PubMed: 25747153 |
Int J Mol Sci | The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension PubMed: 25984599 |
scientific reports | Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone PubMed: 26477337 |
Liver Int | Diabetes enhances the intrahepatic vascular response to endothelin‐1 in cirrhotic rats: association with the ETA receptor and pERK up‐regulation PubMed: 24636620 |
Int J Clin Exp Pathol | Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction PubMed: 26261541 |
Iranian Journal of Pediatrics | NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy serve:4485 |
International Journal of Cardiology | Human myoblast transplantation in mice infarcted heart alters the expression profile of cardiac genes associated with left ventricle remodeling Pubmed:26457413 |
IJC Heart & Vasculature | Cardiovascular changes in patients with non-severe Plasmodium vivax malaria article:S2352-9067(16)30010-0 |
Heart Lung Circ | Soluble Glycoprotein 130 and Heat Shock Protein 27 as Novel Candidate Biomarkers of Chronic Heart Failure with Preserved Ejection Fraction Pubmed:27067668 |
International journal of cardiology | Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies. pubmed:27448535 |
Experimental and Therapeutic Medicine | Expression of pericardial fluid T-cells and related inflammatory cytokines in patients with chronic heart failure. pubmed:28565777 |
Journal of Cardiovascular Electrophysiology | Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure. pubmed:28127817 |
Journal of Cardiovascular Ecography | Study of Vitamin D Status in Patients with Dilated Cardiomyopathy at a Teaching Hospital in North India. pubmed:28465969 |
International Journal of Cardiology | 5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - apreliminary approach to clinical utility. pubmed:27526355 |
Cardiovasc Toxicol | Beneficial Effects of Ozone Therapy on Oxidative Stress, Cardiac Functions and Clinical Findings in Patients with Heart Failure Reduced Ejection Fraction pubmed:28097518 |
Sci Rep. | Serial heart rhythm complexity changes in patients with anterior wall ST segment elevation myocardial infarction. pubmed:28252107 |
Journal of Cardiovascular Magnetic Resonance | The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study pubmed:28065166 |
Repositório Institucional UNESP | AVALIAÇÃO ELETROCARDIOGRÁFICA AMBULATORIAL DE CÃES COM EHRLIQUIOSE MONOCÍTICA CRÔNICA handle:11449 |
Archivos de medicina veterinaria | Cardiac biomarkers in dogs with visceral leishmaniasis S0301-732X2016000300004 |
Original article | Evaluation of N-Terminal Pro Brain Natriuretic Peptide as a biomarker for clinical severity of heart failure in pediatric population Attach432 |
Evidence-Based Complementary and Alternative Medicine | Cardioprotection against Heart Failure by Shenfu Injection via TGF-β/Smads Signaling Pathway pubmed:28698735 |
Scientific Reports | QSKL protects against myocardial apoptosis on heart failure via PI3K/Akt-p53 signaling pathway. pubmed:29209026 |
Vascular Pharmacology | Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats pubmed:29100963 |
Evidence-based complementary and alternative medicine | Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats pubmed:28706558 |
Europace | Prediction of electro-anatomical substrate using APPLE score and biomarkers Pubmed:29893827 |
Heart Rhythm | Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes Pubmed:29604419 |
American Journal of Hypertension | MicroRNAs in Peripheral Mononuclear Cells as Potential Biomarkers in Hypertensive Patients With Heart Failure With Preserved Ejection Fraction Pubmed:29506053 |
International Journal of Molecular Medicine | Differential microRNA expression profiles and bioinformatics analysis between young and aging spontaneously hypertensive rats Pubmed:29328372 |
Biomarkers | Regulation of circulating chromogranin B levels in heart failure Pubmed:29098879 |
Lung | Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension Pubmed:29564533 |
International Journal of Clinical and Exp Medicine | Dynamic monitoring the level of NT-proBNP in assessing the value of cardiac function and prognosis in patients with systemic infection ijcem0072283.pdf |
FASEB Journal | Signature-oriented investigation of the efficacy of multicomponent drugs against heart failure Pubmed: 30230922 |
International Journal of Clinical and Experimental Medicine | Qiliqiangxin ameliorates cardiac dysfunction in heart failure rats post myocardial infarction via activation of HIF/VEGF pathway |
Pediatric Hematology Oncology Journal | Decreasing cardiac iron overload with Amlodipine and Spirulina in children with β-thalassemia Doi: 10.1016/j.phoj.2018.10.001 |
Journal of Clinical Medicine | Acute Responses of Novel Cardiac Biomarkers to a 24-h Ultra-Marathon Pubmed: 30625976 |
Van Veterinary Journal | Relationship between Natriuretic Peptide Levels with Heart and Kidney Parameters in Rats with Chronic Renal Failure. |
Journal of Complementary and Integrative Medicine | Biological markers for the effects of yoga as a complementary and alternative medicine Pubmed: 30735481 |
Frontiers in Pharmacology | Trimetazidine Attenuates Exhaustive Exercise-Induced Myocardial Injury in Rats via Regulation of the Nrf2/NF-κB Signaling Pathway Pubmed: 30890937 |
Journal of Clinical Medicine | Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats Pubmed: 31083544 |
PLoS One | Evaluation of heart rate variability and behavior of electrocardiographic parameters in dogs affected by chronic Monocytic Ehrlichiosis Pubmed: 31125348 |
Cardiovascular Research | Cardio-protective effect of the secretome of Sca-1+ and Sca-1-cells in heart failure–not equal, but equally important? Paracrine cell effects on heart failure |
Advances in Medical Sciences | The potential role of inflammation in cryptogenic stroke |
Disease Markers | Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology Pubmed: 31612072 |
Journal of Human Kinetics | Hormonal Response to Incremental and Continuous Exercise in Cyclists with Left Ventricle Hypertrophy Pubmed: 32148580 |
Nature Communications | Preclinical development of a miR-132 inhibitor for heart failure treatment Pubmed: 32005803 |
MEDIATORS OF INFLAMMATION | Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma Pubmed: 33144847 |
EUROPEAN HEART JOURNAL | CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure Pubmed: 33089304 |
REPRODUCTIVE TOXICOLOGY | Omega-3 polyunsaturated fatty acids alleviate hydrogen sulfide-induced blood-testis barrier disruption in the testes of adult mice Pubmed: 33068716 |
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | Apela improves cardiac and renal function in mice with acute myocardial infarction Pubmed: 32686917 |
J Multidiscip Healthc | Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS 33727824 |
Oxid Med Cell Longev | κ Opioid Receptor Agonist Inhibits Myocardial Injury in Heart Failure Rats through Activating Nrf2/HO-1 Pathway and Regulating Ca2+-SERCA2a 34373768 |
Biology | Hemodynamic Responses in Lower Limb Lymphedema Patients Undergoing Physical Therapy 34356497 |
Arch Acad Emerg Med | Risk Stratification of Pulmonary Thromboembolism using Brain Natriuretic Peptide and Troponin I; a Brief Report Pubmed:35072097 |
Transl Res | Interplay between mineral bone disorder and cardiac damage in acute kidney injury: from Ca2+ mishandling and preventive role of Klotho in mice to its potential … Pubmed:35077866 |
Medicina (Kaunas) | The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment Pubmed:35334593 |
Acta Cardiol Sin | Prothymosin α Gene Transfer Modulates Myocardial Remodeling after Ischemia-Reperfusion Injury Pubmed:35273440 |
Catalog No. | Related products for research use of Canis familiaris; Canine (Dog) Organism species | Applications (RESEARCH USE ONLY!) |
RPA485Ca01 | Recombinant N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA485Ca01 | Polyclonal Antibody to N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) | WB; IHC; ICC; IP. |
CEA485Ca | ELISA Kit for N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) | Enzyme-linked immunosorbent assay for Antigen Detection. |
CCA485Ca | CLIA Kit for N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) | Chemiluminescent immunoassay for Antigen Detection. |
LMA485Ca | Multiplex Assay Kit for N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |